International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A. Arber, Michael R. Savona, Naseema Gangat et al.|Blood|2022Cited by 2.7k
Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|Blood|2013Cited by 1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring SideroblastsElli Papaemmanuil, Peter J. Campbell, Adel K. El‐Naggar et al.|New England Journal of Medicine|2011Cited by 1.2k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Yasuhito Nannya et al.|Nature Medicine|2020Cited by 633
Prediction of Risk for Myeloid Malignancy in Clonal HematopoiesisLachelle D. Weeks, Benjamin L. Ebert, Abhishek Niroula et al.|NEJM Evidence|2023Cited by 294